S
ince the outcome of sepsis is dependent on appropriate and timely treatment (1) , the identification of pathogens and availability of antimicrobial susceptibility testing (AST) should occur as soon as possible (2) . Routinely, positive blood culture (BC) broth is plated onto agar and incubated for 18 to 24 h before inoculation of Vitek 2 cards for combined identification and AST (3, 4) . Recently, the rapid identification of bacteria from positive BCs by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has been reported from cultures very briefly incubated on solid medium (5) . Here, we evaluated the feasibility and accuracy of accelerated AST using the inoculation of Vitek 2 cards with biomass very briefly incubated on agar after subcultivation of positive BC broth.
(This work was presented in part at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, 10 to 13 September 2013, Denver, CO [6] .)
A total of 138 blood samples flagged as positive by an automated BC system (BD Bactec 9240; BD Diagnostics, Heidelberg, Germany) and Gram stained as Gram-positive cocci (GPC) or Gram-negative rods (GNR) were processed as follows: two drops of BC broth were subcultured on Columbia blood agar. Starting from 2 h of incubation at 36°C in air with 5% CO 2 , the plates were inspected hourly, and a 0.5 to 0.63 McFarland standard inoculum was prepared at the first time point at which the growth appeared sufficient. Subsequently, Vitek 2 (bioMérieux SA, Marcy l'Étoile, France) testing was performed. For comparison, a 0.5 to 0.63 McFarland standard inoculum from 24-h cultures was tested by Vitek 2, as recommended by the manufacturer (3). The choice of a definite Vitek 2 AST card was based on the Gram stain from BC broth or/and early MALDI-TOF identification, performed as previously described (5) . AST was done in triplicate, i.e., three AST cards were used for each inoculum to minimize the impact of reproducibility errors on the comparison between rapid and standard testing. The median values were used for analysis. Additionally, the detection of particular resistance mechanisms was evaluated: cefoxitin screening for methicillin resistance in staphylococci, inducible clindamycin resistance in staphylococci and Streptococcus agalactiae, and the production of extended-spectrum ␤-lactamases (ESBL) in Enterobacteriaceae.
Of 138 BCs, 13 ambiguously identified samples, 8 samples with technical errors, 5 isolates that could not be tested by Vitek 2, and 8 mixed cultures were excluded. Thus, 104 isolates (68 GPC and 36 GNR) were available for analysis by rapid AST ( Table 1 ).
The mean time necessary for cultivating plated positive BC broth on agar until successful inoculation of Vitek 2 cards was as short as 3.8 h for GPC and 2.4 h for GNR (Table 2 ). For GPC, inoculation was possible at 4 h in 85.3% of the isolates, with all specimens being inoculated within 7 h (Fig. 1) . At 3 h, inoculation was possible with all GNR isolates, with the exception of a Pseudomonas aeruginosa isolate, which was inoculated at 5 h (Fig. 1) . The mean cultivation times to inoculation of Vitek 2 cards and to an AST result for different bacterial species or groups are shown in Fig. S1 in the supplemental material. An AST result was available 20.2 h and 21.8 h earlier than with the standard method for GPC and GNR, respectively (Table 2) .
Very major error (VME) (false-susceptible result of rapid AST), major error (ME) (false-resistant result of rapid AST), and (Table 3 ) and 0%, 0.5%, 0.8%, 99.2%, and 99.3% for GNR (Table 4) , respectively. In general, the performance of rapid AST in our study was better or similar to that reported in studies using differential centrifugation for the direct inoculation of Vitek 2 cards from positive BCs (7-15). We report error rates here, as required by both the International Organization for Standardization and the U.S. Food and Drug Administration (16, 17) , which recommend that the rate of VME should be calculated using the number of isolates which have been determined as resistant by the reference method as the denominator. To obtain the rate of ME, number of ME should be divided by the number of susceptible isolates determined by the reference method. The mE rate is calculated based on the total number of isolates. Of note, only a minority of studies (7, 10, 15) investigating direct inoculation of Vitek 2 cards for AST presented their results in that way, while the most of studies on rapid Vitek 2 AST reported VME and ME error rates based on the total number of isolates (8, 9, (12) (13) (14) 18) . If calculated based on the number of total isolates, the VME and ME rates are inherently lower and would amount in our study to 0.5% and 0.2% for GPC and 0 and 0.3% for GNR, respectively. One VME (tetracycline in a S. pneumoniae isolate) and no other errors were observed in streptococci. Essential agreement (EA) was observed for all streptococcal isolate-antibiotic combinations.
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ESBL production was reported in eight isolates (7 E. coli and 1 K. pneumoniae) when short-term cultures were used. The standard method identified one additional ESBL producer (E. coli); however, this ESBL phenotype was not confirmed by an additional test. The microbial counts of 0.5 McFarland standard suspensions from the briefly incubated cultures and 24-h cultures were 3.2 ϫ 10 7 and 9.4 ϫ 10 7 CFU/ml, respectively (P Ͻ 0.0001; for a comparison for a subgroup of isolates, see Table S1 in the supplemental material). This difference is not high, which might explain the accuracy of the rapid results.
In conclusion, the inoculation of brief solid medium cultures into Vitek 2 provided early and reliable AST without additional time or cost expenditure. However, further studies are necessary to confirm the reliability of this method with more pathogens with different resistance phenotypes. The thorough control of mature cultures is essential, as mixed cultures can occur. This method can be combined with the rapid MALDI-TOF identification from short-term agar cultures (5). One as a number of isolate-antibiotic combinations for some antibiotics is due to the fact that those antibiotics are analyzed only in the card AST-N248, which was used for testing of the only isolate of P. aeruginosa.
